Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9035692 | 0.76 | FAAH (0.49) | FAAHMGLLHIF1AEPHX2MAPT | |
| Triphenyl Phosphate SCHEMBL28761613 | 0.73 | SRC (0.64) | SRCTDP1L3MBTL1LMNA | |
| Triphenyl Phosphate SCHEMBL28557783 | 0.73 | SRC (0.64) | SRCTDP1L3MBTL1LMNA | |
| Triphenyl Phosphate SCHEMBL483692 | 0.73 | SRC (0.64) | SRCTDP1L3MBTL1LMNA | |
| Triphenyl Phosphate SCHEMBL18116 | 0.73 | SRC (0.64) | SRCTDP1L3MBTL1LMNA | |
| SCHEMBL3716873 | 0.72 | SRC (0.38) | SRCMAPTSMN1; SMN2TDP1L3MBTL1 | |
| Triphenyl Phosphate SCHEMBL9576987 | 0.71 | SRC (0.61) | SRCTDP1L3MBTL1LMNA | |
| Triphenyl Phosphate SCHEMBL7746390 | 0.71 | SRC (0.61) | SRCTDP1L3MBTL1LMNA | |
| Triphenyl Phosphate SCHEMBL15815456 | 0.71 | SRC (0.61) | SRCTDP1L3MBTL1LMNA | |
| Triphenyl Phosphate SCHEMBL2530073 | 0.71 | SRC (0.61) | SRCTDP1L3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1684816-B1 | METHODS OF PREPARING CROSSLINKED MATERIALS AND BIOPROSTHETIC DEVICES | MEDTRONIC INC (US) | 2009-05-06 | — | — | EP | claimed |
| US-20090023698-A1 | METHODS OF MANUFACTURING BIOACTIVE 3-ESTERS OF BETULINIC ALDEHYDE AND BETULINIC ACID | KRASUTSKY PAVEL A | 2009-01-22 | — | — | US | claimed |
| US-20080171906-A1 | TISSUE PERFORMANCE VIA HYDROLYSIS AND CROSS-LINKING | MEDTRONIC, INC. | 2008-07-17 | — | — | US | claimed |
| EP-1684816-A2 | METHODS OF PREPARING CROSSLINKED MATERIALS AND BIOPROSTHETIC DEVICES | Medtronic, Inc. (US) | 2006-08-02 | — | — | EP | claimed |
| US-7053051-B2 | Methods of preparing crosslinked materials and bioprosthetic devices | MEDTRONIC, INC. (US) | 2006-05-30 | — | — | US | claimed |
| US-20050136510-A1 | Methods of preparing crosslinked materials and bioprosthetic devices | MEDTRONIC, INC. | 2005-06-23 | — | — | US | claimed |
| WO-2005042043-A2 | METHODS OF PREPARING CROSSLINKED MATERIALS AND BIOPROSTHETIC DEVICES | MEDTRONIC, INC. (US) | 2005-05-12 | — | — | WO | claimed |
| EP-0898973-B1 | A method of making a crosslinked collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC INC (US) | 2005-01-19 | — | — | EP | claimed |
| EP-0897942-B1 | A method of crosslinking collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC INC (US) | 2004-03-10 | — | — | EP | claimed |
| US-6166184-A | Process for making a bioprosthetic device | MEDTRONIC INC. (US) | 2000-12-26 | — | — | US | claimed |
| US-6117979-A | MIXING AN EPOXY FUNCTIONALIZED CROSSLINKING AGENT WITH COLLAGEN-BASED MATERIAL IN AQUEOUS MEDIUM AT ACIDIC PH; COLLAGEN CARBOXYL GROUPS REACT WITH AGENT; HEART VALVES WITH GOOD MECHANICAL PROPERTIES, RETAIN FLEXIBILITY | MEDTRONIC, INC. (US) | 2000-09-12 | — | — | US | claimed |
| EP-0898973-A2 | A method of making a crosslinked collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC, INC. (US) | 1999-03-03 | — | — | EP | claimed |
| EP-0897942-A1 | A method of crosslinking collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC, INC. (US) | 1999-02-24 | — | — | EP | claimed |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2026-05-21 | — | — | US | disclosed |
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | INSTITUT CURIE (FR) | 2026-01-20 | — | — | US | disclosed |
| US-20250340559-A1 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | INCYTE HOLDINGS CORP (US) | 2025-11-06 | — | — | US | disclosed |
| EP-0897942-A1 | A method of crosslinking collagen-based material and bioprosthetic devices produced therefrom | MEDTRONIC, INC. (US) | 1999-02-24 | — | — | EP | disclosed |
| US-5015698-A | Polyphenylene ether-polyester copolymers, precursors therefor, compositions containing said copolymers, and methods for their preparation | GENERAL ELECTRIC COMPANY (US) | 1991-05-14 | — | — | US | disclosed |
| EP-0248263-A2 | Polyphenylene ether-polyester copolymers precursors therefor, compositions containing said copolymers, and methods for their preparation | GENERAL ELECTRIC COMPANY (US) | 1987-12-09 | — | — | EP | disclosed |
| WO-1987007279-A1 | POLYPHENYLENE ETHER-POLYESTER COPOLYMERS, PRECURSORS THEREFOR, COMPOSITIONS CONTAINING SAID COPOLYMERS, AND METHODS FOR THEIR PREPARATION | GENERAL ELECTRIC COMPANY (US) | 1987-12-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | STXBP1, RNGTT, UPF1 | FAAH 4265/4885MGLL 3171/4885HIF1A 2297/4885 |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | STXBP1, HBB, UPF1 | FAAH 3932/4885MGLL 2950/4885HIF1A 1274/4885 |
| US-20090023698-A1 | METHODS OF MANUFACTURING BIOACTIVE 3-ESTERS OF BETULINIC ALDEHYDE AND BETULINIC ACID | BET1, ALDH7A1, CA7 | FAAH 301/4885MGLL 1744/4885HIF1A 283/4885 |
| US-20250340559-A1 | PROCESSES FOR PREPARING JAK INHIBITORS AND RELATED INTERMEDIATE COMPOUNDS | JAK3, JAK1, JAK2 | FAAH 4414/4885MGLL 4318/4885HIF1A 2870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.